MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

No special precautions for storage.

Provenance

Compatibility recommendation derived from Nebilet 5mg tablets (A. Menarini Farmaceutica Internazionale SRL).

Stability Notes

Does not require any special storage conditions.

Provenance

This compatibility recommendation is derived from Sovaldi 200mg tablets (Gilead Sciences Ltd).

Stability Notes

No special precautions for storage for up to 28 days only based on manufacturer's stability data.

Provenance

This compatibility recommendation is derived from Januvia 25mg tablets (Merck Sharp & Dohme (UK) Ltd).

Stability Notes

No special precautions for storage for up to 28 days only based on manufacturer's stability data.

Provenance

This compatibility recommendation is derived from Januvia 50mg tablets (Merck Sharp & Dohme (UK) Ltd).

Stability Notes

No special precautions for storage for up to 28 days only based on manufacturer's stability data.

Provenance

This compatibility recommendation is derived from Januvia 100mg tablets (Merck Sharp & Dohme (UK) Ltd).

Stability Notes

Protect from moisture. Complex administration regime makes it unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Bondronat 50mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from generic clonazepam 500microgram tablets.

Stability Notes

Orodispersible tablet, therefore unsuitable for MCA

Provenance

This compatibility recommendation is derived from Zomig Rapimelt 2.5mg orodispersible tablets (Grunenthal Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.